Study: Breast imaging with contrast agents needs blood flow monitoring

01/23/2014 | HealthImaging.com

A new study suggests that breast imaging protocols that incorporate injected contrast agents should include monitoring of changes in blood flow caused by mammographic compression, as compression significantly reduces contrast and may affect imaging outcomes. Using diffuse optical and diffuse correlation spectroscopies, researchers noted reductions in total hemoglobin content and blood flow under pressure in 15 healthy patients, according to the study published in Academic Radiology.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health